For immediate release |
18 November 2010 |
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Issue of new ordinary shares
MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that yesterday it issued for cash 1,100,000 new ordinary shares of no par value in the Company (the "New Shares"). The issue price per New Share (before expenses) is 72.75 pence.
The net proceeds will be used in further pursuing the investment objectives of the Company.
The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.
Following this issue, the Company has 142,417,110 ordinary shares in issue.
End
For further information please contact:
MedicX Group: Keith Maddin, Chairman Mike Adams, Chief Executive Officer Mark Osmond, Chief Financial Officer
|
+44 (0) 1483 869 500 |
Collins Stewart Europe Limited: Andrew Zychowski/Lucy Lewis
|
+44 (0) 20 7523 8000 |
Buchanan Communications: Charles Ryland/Lisa Baderoon
|
+44 (0) 20 7466 5000 |
MedicX Fund: David Staples, Chairman
|
+44 (0) 1481 723 450 |
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 35 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.